Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Egan

Showing results (191-200 of 203) with videos related to

Pageof 21
Sort By:
Anesthesia and Analgesia|November 26, 2019
American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on the Role of Neuromonitoring in Perioperative Outcomes: ElectroencephalographyMatthew T V Chan, Traci L Hedrick, Talmage D Egan, et al.
International Journal of STD & AIDS|December 4, 2018
Widespread use of herbal medicines by people living with human immunodeficiency virus and contamination of herbal medicines with antiretrovirals in NigeriaJ Gini, A Amara, Sujan D Penchala, et al.
Journal of Fish Biology|September 18, 2015
An eDNA assay for Irish Petromyzon marinus and Salmo trutta and field validation in running waterM S Gustavson, P C Collins, J A Finarelli, et al.
Science Signaling|August 1, 2023
A spatiotemporal Notch interaction map from plasma membrane to nucleusAlexandre P Martin, Gary A Bradshaw, Robyn J Eisert, et al.
Clinical Pharmacology and Therapeutics|May 28, 2014
A compartmental pharmacokinetic evaluation of long-acting rilpivirine in HIV-negative volunteers for pre-exposure prophylaxisA G A Jackson, L J Else, P M M Mesquita, et al.
Nature Chemical Biology|September 1, 2022
Affinity-matured DLL4 ligands as broad-spectrum modulators of Notch signalingDavid Gonzalez-Perez, Satyajit Das, Daniel Antfolk, et al.
Clinical Pharmacology and Therapeutics|June 6, 2015
Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 StudyL Dickinson, J Amin, L Else, et al.
American Heart Journal|October 31, 2000
Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial diseaseR Garg, M B Elam, J R Crouse, et al.
Controlled Clinical Trials|December 12, 2001
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experienceJ T Wright, W C Cushman, B R Davis, et al.
Anesthesiology|January 1, 1997
Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model developmentC F Minto, T W Schnider, T D Egan, et al.
Pageof 21

Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Anesthesia and Analgesia|November 26, 2019
American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on the Role of Neuromonitoring in Perioperative Outcomes: ElectroencephalographyMatthew T V Chan, Traci L Hedrick, Talmage D Egan, et al.
International Journal of STD & AIDS|December 4, 2018
Widespread use of herbal medicines by people living with human immunodeficiency virus and contamination of herbal medicines with antiretrovirals in NigeriaJ Gini, A Amara, Sujan D Penchala, et al.
Journal of Fish Biology|September 18, 2015
An eDNA assay for Irish Petromyzon marinus and Salmo trutta and field validation in running waterM S Gustavson, P C Collins, J A Finarelli, et al.
Science Signaling|August 1, 2023
A spatiotemporal Notch interaction map from plasma membrane to nucleusAlexandre P Martin, Gary A Bradshaw, Robyn J Eisert, et al.
Clinical Pharmacology and Therapeutics|May 28, 2014
A compartmental pharmacokinetic evaluation of long-acting rilpivirine in HIV-negative volunteers for pre-exposure prophylaxisA G A Jackson, L J Else, P M M Mesquita, et al.
Nature Chemical Biology|September 1, 2022
Affinity-matured DLL4 ligands as broad-spectrum modulators of Notch signalingDavid Gonzalez-Perez, Satyajit Das, Daniel Antfolk, et al.
Clinical Pharmacology and Therapeutics|June 6, 2015
Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 StudyL Dickinson, J Amin, L Else, et al.
American Heart Journal|October 31, 2000
Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial diseaseR Garg, M B Elam, J R Crouse, et al.
Controlled Clinical Trials|December 12, 2001
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experienceJ T Wright, W C Cushman, B R Davis, et al.
Anesthesiology|January 1, 1997
Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model developmentC F Minto, T W Schnider, T D Egan, et al.
Pageof 21